Molecular analysis of T lymphocyte-directed gene therapy for adenosine deaminase deficiency: Long-term expression in vivo of genes introduced with a retroviral vector

Human Gene Therapy

Volumn 7, Issue 9, 1996, Pages 1123-1129

  Mullen, Craig A ^a,d   Snitzer, Karen ^b   Culver, Kenneth W ^b   Morgan, Richard A ^b   Anderson, W French ^c   Blaese, R Michael ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; COMPLEMENTARY DNA; MESSENGER RNA; PHOSPHOTRANSFERASE;

ARTICLE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; EXPRESSION VECTOR; GENE; GENE THERAPY; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ADA; UNIDENTIFIED RETROVIRUS;

EID: 0029945161     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.9-1123     Document Type: Article

References (32)

1. ARREDONDO-VEGA, F.X., KURTZBERG, J., CHAFFEE, S., SANTISTEBAN, I., REISNER, E., POVEY, M.S., and HERSHFIELD, M.S. (1990). Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combined immunodeficiency. J. Clin. Invest. 86, 444-452.
2. BLAESE, R.M., ANDERSON, W.F., CULVER, K.W., and ROSENBERG, S.A. (1990). The ADA human gene therapy clinical protocol. Hum. Gene Ther. 1, 327-362.
3. BLAESE, R.M., CULVER, K.W., MILLER, A.D., CARTER, C.S., FLEISHER, T., CLERICI, M., SHEARER, G., CHANG, L., CHIANG, Y., TOLSTOSHEV, P., GREENBLATT, J.J., ROSENBERG, S.A., KLEIN, H., BERGER, M., MULLEN, C.A., RAMSEY, W.J., MUUL, L., MORGAN, R.A., and ANDERSON, W.F. (1995). T lymphocyte-directed gene therapy for ADA-SCID: Initial trial results after 4 years. Science 270, 475-480.
4. BORDIGNON, C., YU, S.F., SMITH, C.A., HANTZOPOULOS, P., UNGERS, G.E., KEEVER, C.A., O'REILLY, R.J., and GILBOA, E. (1989). Retroviral vector-mediated high-efficiency expression of adenosine deaminase (ADA) in hematopoietic long-term cultures of ADA-deficient marrow cells. Proc. Natl. Acad. Sci. USA 86, 6748-6752.
5. BRAAKMAN, E., VAN BEUSECHEM, V.W., VAN KRIMPEN, B.A., FISCHER, A., BOLHUIS, R.L., and VALERIO, D. (1992). Genetic correction of cultured T cells from an adenosine deaminase-deficient patient: characteristics of non-transduced and transduced T cells. Eur. J. Immunol. 22, 63-69.
6. BROWN, M.S., GOLDSTEIN, J.L., HAVEL, R.J., and STEINBERG, D. (1994). Gene therapy for cholesterol [letter; comment]. Nature Genet. 7, 349-350.
7. COURNOYER, D., SCARPA, M., MITANI, K., MOORE, K.A., MARKOWITZ, D., BANK, A., BELMONT, J.W., and CASKEY, C.T. (1991). Gene transfer of adenosine deaminase into primitive human hematopoietic progenitor cells. Hum. Gene Ther. 2, 203-213.
8. CULVER, K.W., MORGAN, R.A., OSBORNE, W.R.A., LEE, R.T., LENSCHOW, D., ABLE, C., CORNETTA, K., ANDERSON, W.F., and BLAESE, R.M. (1990). In vivo expression and survival of gene-modified T lymphocytes in rhesus monkeys. Hum. Gene Ther. 1, 399-410.
9. DADDONA, P.E., and KELLEY, W.N. (1981). Characteristics of an aminohydrolase distinct from adenosine deaminase in cultured human lymphoblasts. Biochem. Biophys. Acta 658, 280-290.
10. DADDONA, P.E., SHEWACH, D.S., KELLEY W.N., ARGOS, P., MARKHAM, A.F., and ORKIN, S.H. (1984). Human adenosine deaminase: cDNA and complete primary amino acid sequence. J. Biol. Chem. 259, 12101-12106.
11. FERRARI, G., ROSSINI, S., GIAVAZZI, R., MAGGIONI, D., NOBILI, N., SOLDATI, M., UNGERS, G., MAVILIO, F., GILBOA, E., and BORDIGNON, C. (1991). An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency. Science 251, 1363-1366.
12. FERRARI, G., ROSSINI, S., NOBILI, N., MAGGIONI, D., GAROFALO, A., GIAVAZZI, R., MAVILIO, F., and BORDIGNON, C. (1992). Transfer of the ADA gene into human ADA-deficient T lymphocytes reconstitutes specific immune functions. Blood 80, 1120-1124.
13. HERSHRELD, M.S., CHAFFEE, S., and SORENSEN, R.U. (1993). Enzyme replacement therapy with polyethylene glycol-adenosine deaminase in adenosine deaminase deficiency: overview and case reports of three patients, including two now receiving gene therapy. Pediatr. Res. 33, S42-7.
14. HIRSCHHORN, R. (1990). Adenosine deaminase deficiency. Immunodefic. Rev. 2, 175-198.
15. HIRSCHHORN, R., CHAKRAVARTI, V., PUCK, J., and DOUGLAS, S.D. (1991). Homozygosity for a newly identified missense mutation in a patient with very severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID). Am. J. Hum. Genet. 49, 878-885.
16. HOCK, R.A., MILLER, A.D., and OSBORNE, W.R. (1989). Expression of human adenosine deamianse from various strong promoters after gene transfer into human hematopoietic cell lines. Blood 74, 876-881.
17. KANTOFF, P.W., KOHN, D.B., MITSUYA, H., ARMENTANO, D., SIEBERG, M., ZWIEBEL, J.A., EGLITIS, M.A., MCLACHLIN, J.R., WIGINTON, D.A., HUTTON, J.J., HOROWITZ, S.D., GILBOA, E., BLAESE, R.M., and ANDERSON, W.F. (1986). Correction of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 83, 6563-6567.
18. KANTOFF, P.W., GILLIO, A.P., MCLACHLIN, J.R., BORDIGNON, C., EGLITIS, M.A., KERNAN, N.A., MOEN, R.C., KOHN, D.B., YU, S., KARSON, E., KARLSSON, S., ZWIEBEL, J.A., GILBOA, E., BLAESE, R.M., NIENHUIS. A., O'REILLY, R.J., and ANDERSON, W.F. (1987). Expression of human adenosine deaminase in nonhuman primates after retrovirus-mediated gene transfer. J. Exp. Med. 166, 219-234.
19. KOHN, D.E., MITSUYA, H., BALLOW, M., SELEGUE, J.E., BARANKIEWICZ, J., COHEN, A., GELFAND, E., ANDERSON, W.F., and BLAESE, R.M. (1989). Establishment and characterization of adenosine deaminase-deficient human T cell lines. J. Immunol. 142, 3971-3977.
20. MILLER, A.D., and BUTTIMORE, C. (1987). Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6, 2895-2902.
21. MORITZ, T., KELLER, D.C., and WILLIAMS, D.A. (1993). Human cord blood cells as targets for gene transfer potential use in genetic therapies of severe combined immunodeficiency disease. J. Exp. Med. 178, 529-536.
22. NUTMAN, T.B. (1991). Generation and maintenance of T cell lines and clones. In Current Protocols in Immunology. J.E. Coligan, A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, and W. Strober, eds. (John Wiley and Sons, New York) pp. 7.19-7.19.7.
23. PALMER, T.D., HOCK, R.A., OSBORNE, W.R., and MILLER, A.D. (1987). Efficient retrovirus-mediated transfer and expression of a human adenosine deaminase gene in diploid skin fibrobasts from an adenosine deaminase-deficient human. Proc. Natl. Acad. Sci. USA 84, 1055-1059.
24. PALMER, T.D., ROSMAN, G.J., OSBORNE, W.R., and MILLER, A.D. (1991). Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc. Natl. Acad. Sci. USA 88, 1330-1334.
25. RATECH, H., and HIRSCHHORN, R. (1981). Serum adenosine deaminase in normals and in a patient with adenosine deaminase deficient-severe combined immunodeficiency. Clinica Chimica Acta 115, 341-347.
26. REISS, B., SPRENGEL, R., WILL, H., and SCHALLER, H. (1984). A new sensitive method for qualitative and quantitative assay of neomycin phosphotransferase in crude cell extracts. Gene 30, 211-217.
27. SANHSTEBAN, I., ARREDONDO-VEGA, F.X., KELLY, S., MARY, A., FISCHER, A., HUMMELL, D.S., LAWTON, A., SORENSON, R., STEIHM, E.R., URIBE, L., WEINBERG, K., and HERSHFIELD, M.S. (1993). Novel splicing, missense and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. J. Clin. Inv. 92, 2291-2302.
28. SCHRADER, W.P., POLLARA, B., and MEUWISSEN, H. (1978). Characterization of the residual adenosine deaminating activity in the spleen of a patient with combined immunodeficiency disease and adenosine deaminase deficiency. Proc. Natl. Acad. Sci. USA 75, 446-450.
29. VALERIO, D., DUYVESTEYN, M.G., DEKKER, B.M., WEEDA, G., BERKVENS, T.M., VAN DER VOORN, L., VAN ORMONDT, H., and VAN DER EB, A.J. (1985). Adenosine deaminase: Characterization and expression of a gene with a remarkable promoter. EMBO J. 4, 437-443.
30. VAN BEUSECHEM, V.W., KUKLER, A., HEIDT, PJ., and VALERIO, D. (1992). Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone-marrow cells. Proc. Natl. Acad. Sci. USA 89, 7640-7644.
31. WIGINTON, D.A., ADRIAN, G.S., and HUTTON, J.J. (1984). Sequence of human adenosine deaminase cDNA including the coding region and a small intron. Nucleic Acids. Res. 12, 2439-2446.
32. WILLIAMS, D.A., ORKIN, S.H., and MULLIGAN, R.C. (1986). Retrovirus-mediated transfer of human adenosine deaminase gene sequences into cells in culture and into murine hematopoietic cells in vivo. Proc. Natl. Acad. Sci. USA 83, 2566-2570.